United States drug ad war pits Novo Nordisk against Lilly
Novo Nordisk has filed a federal lawsuit in the U.S. District Court for the District of New Jersey accusing Eli Lilly of running deceptive nationwide advertising campaigns for its obesity and diabetes drugs Zepbound and Mounjaro. The complaint, lodged on Tuesday, alleges violations of federal and state false advertising and...